內(nèi)科學(xué)教學(xué)課件:Glomerular Disease_第1頁
內(nèi)科學(xué)教學(xué)課件:Glomerular Disease_第2頁
內(nèi)科學(xué)教學(xué)課件:Glomerular Disease_第3頁
內(nèi)科學(xué)教學(xué)課件:Glomerular Disease_第4頁
內(nèi)科學(xué)教學(xué)課件:Glomerular Disease_第5頁
已閱讀5頁,還剩146頁未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

GlomerularDisease

Conception

Bilateralkidneysareinvolvedinglomerulardisease.Thediseaseiscategorizedinto:Primarydisease:onlyrenalabnormalitySecondarydisease:resultingfromasystemicdisease(SLE,DM).Hereditarydisease:causedbytheabnormalityofhereditarygeneClinicalclassificationofprimaryglomerulardisease1.a(chǎn)cuteglomerulonephritis2.a(chǎn)cuterapidlyprogressiveglomerulonephritis3.chronicglomerulonephritis4.latentglomerulonephritis5.nephroticsyndromeHistologicclassification

ofprimaryglomerulardisease(byWHO)

minorglomerularabnormalitiesfocalsegmentallesions(focalsegmentalglomerulonephritis,focalsegmentalglomerularsclerosisdiffuseglomerulonephritismembranousnephropathyproliferativeglomerulonephritisMesangialproliferativeglomerulonephritisEndocapillaryproliferariveglomerulonephritisMesangialcapillaryglomerulonephritisdensedepositglomerulonephritiscrescenticglomerulonephritissclerosingglomerulonephritisglomerulonephritishavingnotbeenclassifiedPathogenesis1.thedisorderofhumoralimmunityandcellularimmunitywhichcausetheinflammationofkidneys.Pathogenesis2.withtheprogressionofthedisease,someglomeruliaredamaged,thencompensatoryhyperfiltrationandhypertrophyoftheremainingglomerulioccur,whichleadtoglomerulosclerosis.CommonsymptomsofglomerulardiseaseProteinuriaHematuriaEdemaHypertensionRenalinsufficiencyProteinuriaproteinintheurine:>150mg/24hoursor≥(+)Glomerularfilteredbarrierinjury:size-selectivebarriercharge-selectivebarrierHematuria

Whatishematuria?

>3redcells/HP.

PainlessandtotalhematuriaProteinuriaandcastsdismorphicredcellsEdema

(Saltandwaterretention)Nephritisedema;NephroticedemaHypertentionSaltandwaterretentionvolumeoverloadHyperreninemicstates(RAASactiation)ExogenouserythropoietinadministrationDecreaseofantihypertensionsubstanceNephroticSyndromeClinicalmanifestation1.heavyproteinuria:>3.5g/d2.hypoalbuminemia:<30g/L3.edema4.hyperlipidemia

Categorization:primaryandsecondaryNS.Inthesechapter,primaryNSisdiscussed.isessentialforNSPathophysiologyofnephroticsymdromheavyproteinuriaThedamageofsize-selectivebarrierand/orcharge-selectivebarrieroftheglomerularfiltrationbarrier.adecreaseofserumproteinlose:alargeamountofproteinislostthroughurineDecompositiondecomposedbytheepithelialofproximaltubule.synthesis:whentheliversynthesiscannotcompensatetheloseanddecompositionofprotein,thenhypoproteinemiaoccur.inadequateintakeofproteinmayalsoleadtohypoproteinuria.edemahypoalbuminemia→colloidosmoticpressure↓→watersmovingfromcapillarytotissueSodiumretentionHyperlipidemia(hypercholestrolemia,hypertriglyceridemiaandlowdensitylipoproteins(LDL)

Thisisbecausethesynthesisofproteinbytheliverincreaseandthedecompositionofproteindecrease.EtiologyInpatientswithdifferentages,themostcommondiseaseare:InprimaryNS:children:minimalchangediseaseSenilepatient:membranousnephropathyAdolescentpatient:mesangialproliferativeglomerulonephritismesangialcapillaryglomerulonephritisfocalsegmentalglomerularsclerosisInsecondarydiseaseChildren:congenitalnephroticsyndromeanaphylactoidpurpurahepatitisBvirusassociatednephritis.YoungpatientslupusnephritisanaphylactoidpurpurahepatitisBvirusassociatednephritis.Senilepatients:diabeticnephropathymultiplemyeloma.

DifferentialDiagnosisNephritisresultfromanaphylactoidpurpura.

palpablepurpura,arthralgias,andabdominalsymptomssuchasnausea,colic,andmelena.lupusnephritisarthralgias,skinlesions(butterfly,discoidrash),etc.ANA+,DsDNA+,C3↓Diabetesnephropathy:inadultsoccuraftermorethan10yearsofdiabetes.WhenNSoccur,itprogresstorenalfailurerelativelyquickly.DifferentialDiagnosisAmyloidosis:

insenilepatients.Manyorganscanbeinvolved.biggerkidneythannormal.Renalbiopsyisthediagnosticway.multiplemyeloma.adults,amalepredominance.bonepaininthelowerbackmonoclonalparaproteinbyserumorurinemalignantplasmacellsinbonemarrowHistologictypeandit’sclinicalfeatures

minimalchangediseasemesangialproliferativeglomerulonephritismesangialcappilaryglomerulonephritismembranousnephropathyFocalsegmentalglomerularsclerosisMinimalchangedisease(MCD)

histologicalterations

lightmicroscopy:

noglomerularlesions,lipidresorptiondropletsintubularepithelialcellselectronmicroscopy

anextensivefootprocesseffacementimmunofluorescencemicroscopy:negative

微小病變型Figure1.minimalchangedisease.Left:normalglomeruleright:abnormalglomerule.1.anextensivefootprocesseffacement2.basementmembrane3.endothelialcell4.mesangialcellminimalchangedisease微小病變型腎病綜合征。腎小球毛細(xì)血管壁呈典型的腎病綜合征改變:彌漫足突(FP)融合。尿腔內(nèi)微絨毛(MV)形成,足細(xì)胞(P)水腫,內(nèi)皮細(xì)胞(En)輕度腫脹。EMx17000Clinicalfeatures:mostcommonlyseeninchildren,accountingfor70-90%ofNSinchildren.Itcanalsobeseeninadults,particularlyinsenilepatient.hematuria:about10%-20%,nomacroscopichematuria.atransienthypertensionsensitivetosteroidsmesangialploliferativeglomerulonephritis

Histologicalterationslightmicroscopy:

mesangialhypercellularityandincreaseofmatrix.Itcanbedividedintomild,moderate,severealterations.immunofluorescencemicroscopy:

IgAnephropathynonIgAnephropathyelectronmicroscopy:

mesangialelectron-densedeposit

Figure2:mesangialploliferativeglomerulonephritis

Left:normalglomeruleright:abnormalglomerule.1.Epithelialcell2.basementmembrane3.endothelialcell4.mesangialcell5.immunecomplexmildploliferationmoderateploliferationsevereploliferation免疫熒光:IgG系膜區(qū)沉積系膜增生性腎小球腎炎。顯示系膜增生和散在的沉積物(D)。EMx7000clinicalfeatureahighincidence,commonlyseeninadolescent,dromalinfectioncanbeseen.hematuria:100%inIgAnephropathy,about70%innon-IgAnephropathy.sensitivetosteroidandcytotoxicdrugs,butcloselyassociatedwithseverityofhistologiclesions.mesangialcapillaryploliferativeglomerulonephritis(membran-oproliferativeglomerulonephritis)

histologicalterationslightmicroscopy:

endocapillaryhypercellularity,themesangialhypercellurarityandincreaseofmatrixwhichcaninsertbetweenendothelialandbasementmembraneandthenadoubletracksisformed.immunofluorescencemicroscopy:

mainlythedepositionofC3andIgG.Electronmicroscopy

electron-densedepositinmesangiumandalongcapillarywallcanbeseen.Figure2:mesangialcapillaryglomerulonephritis

Left:normalglomeruleright:abnormalglomerule.1.Epithelialcell2.basementmembrane3.endothelialcell4.mesangialcell5.immunecomplex6.basementmembranematerialalike.左為系膜毛細(xì)血管性腎炎,右為正常腎小球系膜毛細(xì)血管性腎小球腎炎(I型)。腎小球系膜區(qū)增寬,毛細(xì)血管壁增厚,局部雙軌形成。PASx260doubletracksclinicalfeaturecommonlyseeninadults,amaleprevalence.hematuria:

allexhibithematuria,macroscopichematuriaiscommon.serumC3↓anddonotrecovertonormal

clinicalfeaturerenalfunctionfailure,hypertensionandanemiaappearsearly.onlyapartofchildrenrespondtosteroidsandcytotoxicdrugs,theremainsdonotrespondwell.

membranousnephropathyhistologicalterations

lightmicroscopy:

aspikepattern,basementmembranethickenesswithoutinflammatorychanges.Electronmicroscopy:

densedepositsalongthesubepithelialsurfaceofthebasementmembrane.Spikesandeffacementoffootprocesscanbeseen.immunofluorescencemicroscopy:

IgGandC3alongcapillaryloopsFigure4:membranousnephropathy

Left:normalglomeruleright:abnormalglomerule.

1.Epithelialcell2.basementmembrane3.endothelialcell4.mesangialcell5.immunecomplexclinicalfeatures

commonlyseeninadults,amalepredominance,commonlyintheirfifthandsixthdecades.occurindolentlydevelopslowly:often5-10years→renalfailureclinicalfeatures

patientsarepronetothrombosisandthromboembolism.25%mayhaveacompletelyspontaneousremission.Beforeappearanceofspikes,patientsaresensitivetosteroidsandcytotoxicdrugs.Afterspikesappears,patientsdonotrespondtotreatmentwell.focalsegmentalsclerosis

histologicalterations

lightmicroscopy:

Focalandsegmentalglomerularsclerosis.Electronmicroscopy:Densedepositsalongthesubendothelialsurfaceofthebasementmembrane.effacementoffootprocesscanbeseen.immunofluorescencemicroscopy:

StainingofIgMandC3canbeseeninthelesionsites.

局灶節(jié)段性腎小球硬化Focalandsegmentalglomerularsclerosisclinicalfeatures

commonlyseeninadolescencedeveloplatently.hematuria:oftenseen,20%exhibitmacroscopichematuria.Oftenproximaltubulardysfunction:glucose,aminoacidinurineDosenotrespondtosteroidandcytotoxicdrugswell.Onlyasmallpartofpatientsaresensitivetothetreatment.ComplicationofNSsusceptibilitytoinfectionCause:proteinmalnutrition,immunitydysfunction,administrationwithsteroids.Infectionseencommonly:respiratorytract,urinarytractinfectionandperitonitis,etc.ItwillinfluencetheeffectoftreatmentorleadtorelapseofNS.

Thrombosisandthromboembolism

cause:ImbalanceofCoagulationandanticoagulationsystem.increasedplateletactivationbloodviscositysteroidspromptthehypercoagulationstate.

Renalveinthrombosisandothervenousthromboemboli.acuterenalfailure

Cause:colloidosmoticpressure↓→hypovolemia→renalhypoperfusion→prerenalazotemiathetubulepressedbyextremeedemaoftheinterstitium.thetubulebeingblockedbyalargeamountofproteincastwhichleadtoadecreaseofGFR.

metabolicdisturbanceofproteinandlipidDiagnosisanddifferentialdiagnosis

Diagnosis:includingisitNS?Yesorno.Yes,thenIsitprimaryNS?PrimaryNS,thenwhatkindofglomerulardisease?Histologictype.Aretherecomplications?Treatment1.diet:Protein:0.8~1.0g/(kg·d),Sodiumrestriction:2.Edema:

dietarysaltrestrictiondiuretictherapy:thiazideandloopdiureticsTreatment3.ReducingproteinuriaACEI

machanism:

loweringefferentarteriolarresistanceoutofproportiontoafferentarteriolarresistance→reducingglomerularcapillarypressureandloweringurinaryproteinexcretion.

Sideeffect:

worseningrenalfailureandhyperkalemia.4maintreatmentGlucocorticoid:

inhibitinginflammatoryreactionandimmunereaction,thesecretionofaldosteroneandADH↓.principle:sufficient

dosageshouldbegivenatthebeginning:prednisone1mg/(kg·d)for8-12weeks4maintreatmentGlucocorticoid:

principle:tapeslowly

tapethemedicinewithaspeedof10%ofthebeginningdoseevery1-2weeks.Whenitreach20mg/d,itisveryeasiertorelapse,themedicineshouldbetapedmoreslowly.4maintreatmentGlucocorticoid:

principle:Maintenanceofthemedicineforalongterm

10mg/doftenatleast6months.(prednisonecanbetakenoncedailyinthemorning)Sideeffectsofglucocorticoid:prolongedcorticosteroidtherapymayleadtoAlifethreateninginfectionOsteoporosisDiabetesmellitusAcceleratedatherosclerosisHypertensionGastritisorpepticulcerMentalillnessglucocorticoid:

accordingtotheresponsetoglucocorticoid,itcanbecategorizedintothreegroups:steroid-sensitiveremissionisachievedafter8~12weeksoftreatmentsteroid-dependentthediseaserelapseduringprednisonereducingsteroid-resistantnoeffectcanbeachievedafter8-12weeksoftreatment.4maintreatmentCytotoxicdrugsusedwhenpatientsaresteroid-dependentorsteroid-resistant.Generally,itisnotusedaloneorasprimarychoice.CyclophosphamideItcanbeusedorallyorbyintravenousway.Untilwhenthetotaldosereach6~8gor150mg/kg。Sideeffectsofcyclophosphamide:

BonemarrowsuppressionLivertoxicityGonadaldysfunctionLossofhairSymptomsofdigestivesystem:vomiting,nausea,abadappetite,etc.HemorrhagiccystitisCyclosporin

Applicabilityusedinrefractorynephroticsyndromeunresponsivetocorticosteroidandcyclophosphamide.Doses5mg/kg·dadministeredorallyin2divideddose.Cyclosporin

RelapseOncecyclosporineisdiscontinued,therelapseofnephrosisoccureasily.Analternativewaytothetreatmentisusinggraduallylowerdosesinordertomaintainthepatientinremission.Sideeffectsliverandkidneytoxicity,hypertension,TherapyfordifferenthistologictypeofnephroticsyndromeMinimalchangediseaseandmildmesangialproliferativeGN:

Corticosteroidisthemaintherapy.Ifthediseaseisunresponsivetothetherapyorrelapsefrequently,thencytotoxicdrugscanbeconsidered.

Membranousnephropathy:Itshouldbetreatedaggressively,Corticosteroidandcytotoxicdrugsshouldbeused.But,afterthetreatmentcourseisfinished,thesedrugsshouldnotbeusedwithabigdosefortoolongaterm.MembranousnephropathyHyperlipidemiaandhypercoagulablestateshouldbecontrolledtopreventthrombosisandthromboembolism.focalsegmentalglomerularsclerosis,severemesangialproliferativeglomerulonephritis,mesangialcapillaryglomerulonephritisIfrenaldysfunctionhasoccurred,thenusuallycorticosteroidandcytotoxicdrugsarenotgiven.focalsegmentalglomerularsclerosis,severemesangialproliferativeglomerulonephritis,mesangialcapillaryglomerulonephritisIfrenalfunctionisnormal,sufficientdoseofcorticosteroidandcytotoxicdrugsshouldbegivenandthentapeslowly,anddrugsforanti-coagulationandanti-aggregationofplateletscanbeadministersimultaneously.Treatmentforcomplicationinfection:

antimicrobialsensitiveforpathogenandwithoutnephrotoxicityshouldbegivenpromptly.Thrombosisandthromboembolism.ALB<20g/L,patientscanbecomehypercoagulable.

drugsHeparinasmalldoseofaspirin

thrombosistreatmentthrombolytictherapy(bestusedwithin6hours,itisprobablyeffectivewithin3days.)streptokinasecanbeused.Acuterenalfailure

abigdoseofloopdiureticshemodialysisalkalizingtheurinemetabolicdisturbanceofproteinandlipidACEIcanalleviateproteinuriaAntihyperlipidemia:HMC-CoAreductaseinhibitorsPrognosisFactorsthataffecttheprognosishistologictypeClinicalpresentations:heavyproteinuria,hypertension,hyperlipidimia,anemia,plicationTotakehomepointsTalkingaboutthenephroticsymdrom(NS).WhatisclinicalthoughofNS.

WhatisHistologictypeofNSandit’sclinicalfeatures?TotakehomepointsTalkingaboutthecomplicationofNS?TalkingabouttheapplicationofglucocorticoidinNSandit’sSideeffects.Chronicglomerulonephritis

PanLing

Conception:

Chronicglomerulonephritisreferstoagroupofglomerulardiseasethatdevelopslowlyandeventuallyleadtochronicrenalfailure.Mechanism1.

Immune-mediated

inflammatoryreaction2.Non-immuneornon-inflammatoryfactors3.AcuteChronic

immunecomplexinsitu

circulatingimmunecomplexesHistologicalterationsMesangialproliferativeglomerulonephritisMesangialcapillaryglomerulonephritisMembranousnephropathyFocalsegmentalglomerularsclerosisSclerosingglomerulonephritis

Mesangialproliferative

glomerulonephritis

Mesangialcapillary

glomerulonephritisMembranousNephropathy

Focalsegmental

glomerulosclerosis

SclerosingglomerulonephritisDiffuseinfiltrationofneutrophilininterstitumClinicalmanifestationsandlaboratoryfindingsCommonlyseeninadults,amalepredominance.Generallyoccurindolently.Somepatientspresentasacutenephriticsymdromewithprodromalinfection.(MSPGN.MPGN)Clinicalpresentations

ProteinuriaHematuriaEdemaHypertensionRenalinsufficiencyClinicalpresentations

Proteinuria:A.1~3g/d.B.Glomerularproteinuriacause:abnormalitiesintheglomerularfiltrationbarriercharacteristic:bigormiddlemolecularproteinClinicalpresentations

Hematuria:A.GlomerularhematuriaPainlessandtotalhematuriaProteinuriaandcastsphasecontrast

microscopy:multiformity

typeandmixedtype

RBCinurineincreased>80%;Acanthoiderythrocytes>5%EVDC:asymmetricalcurve

棘形RBCClinicalpresentations

Edema--Nephritisedeman(morning,eyelid,face)

glomerulotubularimbalanceeGFR↓capillarypermeability↑RAAS↓ADH↓Clinicalpresentations

Hematuria:B.Mainlyinpatientswithproliferativeorfocalhistologicalterations→itcanbemacroscopichematuriaClinicalpresentations

HypertensionSaltandwaterretentionvolumeoverloadHyperreninemicstates(RAASactiation)ExogenouserythropoietinadministrationDecreaseofantihypertensionsubstanceHBP

Clinicalpresentations

Renalinsufficiency---DifferentdegreeSerumcreatinine↑

Ccr↓eGFR↓UrinevolumeabnormalChronicprogressionofthediseaseisassociatedwith:

HistologictypeTherapycondition.Theexistofworseningfactors:tiredness,infection,uncontrolledhypertension,nephrotoxicdrugs.DiagnosisanddifferentialdiagnosisDiagnosis:Clinicalmanifestation:

proteinuia,hematuria,edema,hypertension,renalinsufficiency.Secondaryandhereditaryglomerulonephritisshouldbeexcluded.Course>3M,mostonsethidden,complicationBultrasound:bilateralsmallkidney

2.DifferentialdiagnosisSecondaryGN:

lupusnephritis,anaphylactoidpurprua.Alportsyndrome

commonlyseeninchildren(<10ys)abnormalityofrenal,eyesandearsexistsimultaneously.Apositivefamilyhistoryisfound.Otherprimaryglomerulonephritis

AcuteGNpostinfection:mainlyseeninchildrenprodromalsymptom:1-3weeksbeforehematuria:almost100%serumC3

,yetrecovertonormallevelwithin8weeks.Otherprimaryglomerulonephritis

AcuteGNpostinfection:histologiclesions:endocapillaryproliferativeGN

favorableprognosisinchildren,butadultsaremorepronetochronicrenalinsufficiency.Renaldamagecausedbyprimaryhypertensionrenaldamageisseenafteralongtermofhypertension.tubulardysfunctionoccurearlierthanglomerulardysfunction.Renaldamagecausedbyprimaryhypertensionotherta

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

最新文檔

評論

0/150

提交評論